Understanding premenstrual syndrome

Lancet

Volumn 351, Issue 9101, 1998, Pages 465-466

  Berga, S L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ALPRAZOLAM; PREGNENOLONE; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LUTEAL PHASE; OVARY FUNCTION; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROGESTERONE METABOLISM; SHORT SURVEY; TRANQUILIZING ACTIVITY;

EID: 0032515562     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78679-7     Document Type: Note

References (8)

1. AJ Rapkin M Morgan L Goldman DW Brann D Simone VB Mahesh Progesterone metabolite allopregnanolone in women with premenstrual syndrome Obstet Gynecol 90 1997 709 714
2. E Freeman K Rickels SJ Sondheimer M Polansky Ineffectiveness of progesterone suppository treatment for premenstrual syndrome JAMA 264 1990 349 353
3. PJ Schmidt LK Nieman MA Danaceau LF Adams DR Rubinow Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome N Engl Med J 338 1998 209 216
4. E Freeman K Rickels SJ Sondheimer M Polansky A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome JAMA 274 1995 51 57
5. M Steiner S Steinberg D Stewart Fluoxetine in the treatment of premenstrual dysphoria N Engl J Med 332 1995 1529 1534
6. KA Yonkers U Halbreich E Freeman Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial JAMA 278 1997 1024 1025
7. DS Reddy SK Kulkami Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice Brain Res 752 1997 61 71
8. R Rupprecht The neuropsychopharmacological potential of neuroactive steroids J Psychiatr Res 31 1997 297 314